| 2009 | CYP2C19 haplotypes in Koreans as a marker of enzyme activity evaluated with omeprazole | 이화정 | Article |
| 2009 | Altered bone morphogenetic protein and transforming growth factor-β signaling in rat models of pulmonary hypertension. Potential for activin receptor-like kinase-5 inhibition in prevention and progression of disease | 김대기 | Article |
| 2007 | Synthesis of 6-chloroisoquinoline-5,8-diones and pyrido[3,4-b]phenazine-5,12-diones and evaluation of their cytotoxicity and DNA topoisomerase II inhibitory activity | 유충규; 박혜영; 이상국; 이화정 | Article |
| 2006 | Synthesis of 5-ethyl-2-{5-[4-(2-hydroxyethyl)piperazin-1-ylsulfonyl]-2-n- propoxyphenyl}-7-n-propyl-3,5-dihydro-4H-pyrrolo[3,2-d]-[2-14C] pyrimidin-4-one · 2 HCl (14C-SK3530 · 2 HCl) | 김대기 | Article |
| 2012 | Synthesis and biological evaluation of 2-benzylamino-4(5)-(6-methylpyridin- 2-yl)-5(4)-([1,2,4]triazolo[1,5-a]-pyridin-6-yl)thiazoles as transforming growth factor-β type 1 receptor kinase inhibitors | 신윤용; 김대기; 김승원 | Article |
| 2009 | Long-term administration of an aqueous extract of dried, immature fruit of Poncirus trifoliata (L.) Raf. suppresses body weight gain in rats | 서은경 | Article |
| 2009 | Pattern recognition analysis for the prediction of adverse effects by nonsteroidal anti-inflammatory drugs using 1H NMR-based metabolomics in rats | 이화정 | Article |
| 2008 | A simple HPLC method for the quantification of mizoribine in human serum: Pharmacokinetic applications | 이화정 | Article |
| 2008 | Pharmacokinetics and tissue distribution of 3-((5-(6-methylpyridin-2-yl)-4- (quinoxalin-6-yl)-1H-imidazol-2-yl)methyl)benzamide; a novel ALK5 inhibitor and a potential anti-fibrosis drug | 신윤용; 이화정; 김대기 | Article |
| 2008 | Synthesis and biological evaluation of 5-(pyridin-2-yl)thiazoles as transforming growth factor-β type1 receptor kinase inhibitors | 김대기 | Article |
